NCT06482801
- Conditions
- Adenocarcinoma, Antibody, Carcinoma, +10 more
- Locations
-
- Second Affiliated Hospital of Guangzhou Medical University Guangzhou, China
Clinical trial condition
Antibody
Explore clinical trials studying Antibody. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Antibody trial results
NCT06168032
- Conditions
- Antibody, COVID-19 Recurrent, Chemotherapy, +10 more
- Locations
-
- Peking Union Medical College Hospital Beijing, China
Enrolling by Invitation
Prevention of Rabies With Four Doses of Rabies Vaccine
NCT05545371
- Conditions
- Antibody, Rabies Human
- Locations
-
- Changchun Zhuoyi Biological Co., Ltd Changchun, Jilin, China
NCT05547815
- Conditions
- Antibody, Infections, Mononegavirales Infections, +4 more
- Locations
-
- Changchun Zhuoyi Biological Co., Ltd Changchun, Jilin, China
NCT05305261
- Conditions
- Antibody, COVID-19, Cone-Rod Dystrophies, +21 more
- Locations
-
- UKM Medical Center Kuala Lumpur, W.Persekutuan, Malaysia
Active, Not Recruiting
A Pan-Cancer Retrospective Study on the Relationship Between Tumor Microenvironment Composition and Efficacy of Antibody-Based Antitumor Therapy
NCT07584044
- Conditions
- Antibody, Tumor Microenvironment
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China